Tema Oncology ETF (CANC)

Assets	$18.64M
Expense Ratio	0.75%
PE Ratio	26.86
Shares Out	680,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	2,124
Open	27.16
Previous Close	27.41
Day's Range	27.03 - 27.31
52-Week Low	2.89
52-Week High	29.16
Beta	1.11
Holdings	49
Inception Date	Aug 15, 2023

About CANC

Fund Home Page

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.

• Asset Class: Equity
• Stock Exchange: NASDAQ
• Ticker Symbol: CANC
• ETF Provider: Tema

Top 10 Holdings

37.95% of assets

Name	Symbol	Weight
Regeneron Pharmaceuticals, Inc.	REGN	5.48%
Merck & Co., Inc.	MRK	5.21%
Daiichi Sankyo Co Ltd	4568.T	4.33%
AstraZeneca PLC	AZN.L	3.86%
Novartis AG Registered Shares	NOVN.SW	3.48%
Illumina, Inc.	ILMN	3.24%
Amgen Inc.	AMGN	3.22%
Revolution Medicines, Inc.	RVMD	3.22%
Exact Sciences Corporation	EXAS	2.95%
argenx SE	ARGX	2.94%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 13, 2023	$0.14911	Dec 15, 2023